Key facts
- This page summarizes Rupert Vessey's Form 4 filing for BIO-TECHNE Corp (TECH).
- 2 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2025, 17:23.
Rupert Vessey - 30 Oct 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)
- Reporting relationship
- Director
- Issuer ticker
- TECH
- Reported as of
- 30 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Nov 2025, 17:23:10 UTC
- Prior SEC filing
- 28 Oct 2024
- Next SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Nick as Attorney-in-Fact for Rupert Vessey pursuant to Power of Attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rupert Vessey filed Form 4 for BIO-TECHNE Corp (TECH) on 03 Nov 2025.
Change
- Previous filing in this sequence was filed on 28 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001677618
Primary reporting owner
Vessey Rupert
- Relationship
- Director
- Address
- 614 MCKINLEY PL NE, MINNEAPOLIS
- Signature
- /s/ Andrew Nick as Attorney-in-Fact for Rupert Vessey pursuant to Power of Attorney previously filed
- Signature date
- 03 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TECH
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,640
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 10,987
- Date
- 30 Oct 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TECH
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,777
- Change %
- Price
- $0.000000
- Shares after
- 3,777
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,777
- Exercise price
- $60.96
- Footnotes
- F1
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,044
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,044
- Exercise price
- $50.41
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,352
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,352
- Exercise price
- $52.32
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,028
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,028
- Exercise price
- $63.92
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,532
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,532
- Exercise price
- $128.81
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,460
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,460
- Exercise price
- $73.94
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,937
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,937
- Exercise price
- $61.51
TECH
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,511
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,511
- Exercise price
- $68.37
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.